Quality of life and pain in dogs with early-stage mammary tumours

Lallo, Maria Anete

doi:10.1556/004.2015.042

Cited by 5 publications

(4 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Oncologic dogs were reported to have a lower QoL than healthy dogs, and such data agree with previous literature on the topic [ 18 , 19 ]. The assessment of QoL in the oncologic patient is important to decide and modulate therapeutic choices [ 28 ] as well as to understand the effects of disease and treatment on the animal [ 29 ].…”

Section: Discussionsupporting

confidence: 91%

“…The comparison with oncologic patients, on the other hand, provided rather unexpected results. In fact, the control group of oncological dogs was recruited as the impact of oncological disease on patients’ QoL, including canine patients, is well-recognized [ 18 , 19 ].…”

Section: Discussionmentioning

confidence: 99%

“…For instance, in human medicine, it has been shown that chronic intestinal pathologies can have a significant impact on HRQoL [ 9 , 13 , 14 , 15 ] as well as on behavioral aspects, with the possible onset of psychological–psychiatric disorders such as anxiety and depression [ 15 , 16 , 17 ]. As for dogs, specific studies on QoL are available mainly for oncological canine patients [ 18 , 19 ] and, in a retrospective study, for a population of enteropathic dogs [ 20 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Impact of Chronic Inflammatory Enteropathy on Dogs’ Quality of Life and Dog-Owner Relationship

Marchetti

Gori

Mariotti

et al. 2021

Veterinary Sciences

View full text Add to dashboard Cite

This research was aimed at evaluating the impact of canine chronic enteropathies on dogs’ quality of life (QoL), their behavior, and owner–dog relationship. Forty-four dogs suffering from primary chronic enteropathies were assessed on the first visit with a veterinary gastroenterologist and on the first follow-up visit using a 1–10 visual scale to evaluate five features of QoL, the Canine Chronic Enteropathy Clinical Activity Index, the Lexington Attachment to Pet Scale, and the Canine Behavioral Assessment and Research Questionnaire. They were compared to a control group of 49 healthy dogs and to a group of 50 dogs suffering from cancer. QoL and severity of enteropathy were negatively associated; enteropathic dogs on the first visit had a lower QoL than healthy dogs for all features and a lower general QoL than cancer patients; enteropathic dogs on the follow-up visit improved significantly for general QoL, health QoL, and interaction QoL. Higher levels of attachment between the owner and the dog were obtained for dogs affected by chronic enteropathies. Finally, dogs showed higher scores for separation-related behaviors and contact/attention behaviors on the first visit than on the subsequent follow-up. As in human medicine, chronic enteropathies have a strong negative impact on dogs.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Impact of Chronic Inflammatory Enteropathy on Dogs’ Quality of Life and Dog-Owner Relationship

Marchetti

Gori

Mariotti

et al. 2021

Veterinary Sciences

View full text Add to dashboard Cite

show abstract

“…Several studies had been dedicated to the quality of life of the chemo-patient, through owners' perception. [11,13,[21][22][23][24] In our study, through the owner's answers of the questionnaire, we concluded that life quality of the patients with canine lymphoma that received chemotherapy was not impaired, and even improved in most of them. The general positive impression given by the owners indicates that chemotherapy is relevant and worthwhile in dogs with lymphoma.…”

Section: Discussionmentioning

confidence: 81%

Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma

2023

View full text Add to dashboard Cite

Lymphoma is the most common hematopoietic tumor in dogs. The standard diagnostic approach and staging includes detailed clinical history, physical examination and extended laboratory workup including lymph node cytology. Multidrug chemotherapy is the main treatment of the disease. Often, owners are concerned about the side effects of the treatment and the quality of life of their dog during chemotherapy. The aim of this study was to analyze the health related wellbeing of the patients with lymphoma previous, during and at the end of the chemotherapy. Five patients with multicentric lymphoma were monitored in three phases (beginning, middle and end of chemotherapy). The monitoring included clinical examination, laboratory analyses and a questionnaire for the owner. Results revealed significant improvement (p< 0.1) of the basic red blood cells parameters (RBC, PCV and Hb), platelets (PLT) as well as liver enzymes (ALT, AST) and protein status (total protein and globulin). Regarding the life quality assessed by the owners, dogs' appetite, general health compared to each visit and the current quality of life were significantly improved (p<0.1) and all of the owners were satisfied with the decision for chemotherapy.

show abstract

Health‐related quality of life in dogs treated with electrochemotherapy and/or interleukin‐12 gene electrotransfer

Milevoj

Tozon

Ličen

et al. 2020

Veterinary Medicine & Sci

View full text Add to dashboard Cite

The aim of this study was to evaluate the owners' perception of health‐related quality of life (HRQoL) of dogs after treatment with electrochemotherapy (ECT) alone or combined with interleukin‐12 gene electrotransfer (IL‐12 GET) and/or surgery. The owners of 44 dogs with histologically different tumours were offered the »Cancer Treatment Form« at least one month after treatment. The owners assessed their dogs’ quality of life (QoL) after treatment as good (mean 7.4) (from 1–very poor to 10–excellent) and the general health compared with the initial diagnosis of cancer as improving (mean 3.9) (from 1–worse to 5–better). The assessment of the current QoL was better within the group of dogs treated with non‐invasive treatment (ECT and/or IL‐12 GET only), compared with those that received invasive treatment, where, in addition to ECT and/or IL‐12 GET, surgery was performed ( p < .05). The owners of dogs that achieved an objective response (OR) to the treatment assessed the QoL as significantly better compared with those whose dogs did not respond to the treatment ( p < .05). The majority of the owners (86.4%) would opt for the therapy again, regardless of the financial costs. In conclusion, the results of this study demonstrate that the majority of the owners of dogs assessed their dogs’ QoL as good and felt that it improved after the treatment, especially in dogs, treated with non‐invasive treatment and in those that responded to the treatment . This supports further use of ECT and IL‐12 GET as suitable methods for the treatment of selected tumours in veterinary medicine.

show abstract

Quality of life and pain in dogs with early-stage mammary tumours

Cited by 5 publications

References 16 publications

The Impact of Chronic Inflammatory Enteropathy on Dogs’ Quality of Life and Dog-Owner Relationship

The Impact of Chronic Inflammatory Enteropathy on Dogs’ Quality of Life and Dog-Owner Relationship

Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma

Health‐related quality of life in dogs treated with electrochemotherapy and/or interleukin‐12 gene electrotransfer

Contact Info

Product

Resources

About